Clinical Trial Update: Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on nab-paclitaxel and S-1 in locally advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Locally Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN